Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Lack of sibling avoidance during mate selection in the butterfly Bicyclus anynana.

Robertson DN, Sullivan TJ, Westerman EL.

Behav Processes. 2020 Apr;173:104062. doi: 10.1016/j.beproc.2020.104062. Epub 2020 Jan 22.

PMID:
31981681
2.

Design and construction of conformational biosensors to monitor ion channel activation: A prototype FlAsH/BRET-approach to Kir3 channels.

Robertson DN, Sleno R, Nagi K, Pétrin D, Hébert TE, Pineyro G.

Methods. 2016 Jan 1;92:19-35. doi: 10.1016/j.ymeth.2015.07.011. Epub 2015 Jul 22.

PMID:
26210401
3.

Persistent virus-induced gene silencing in asymptomatic accessions of Arabidopsis.

Flores MA, Reyes MI, Robertson DN, Kjemtrup S.

Methods Mol Biol. 2015;1284:305-22. doi: 10.1007/978-1-4939-2444-8_15.

PMID:
25757779
4.

Virus-induced gene silencing of fiber-related genes in cotton.

Tuttle JR, Haigler CH, Robertson DN.

Methods Mol Biol. 2015;1287:219-34. doi: 10.1007/978-1-4939-2453-0_16.

PMID:
25740368
5.

Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.

Tudashki HB, Robertson DN, Schiller PW, Pineyro G.

Mol Pharmacol. 2014 Jan;85(1):148-61. doi: 10.1124/mol.113.089003. Epub 2013 Oct 30.

6.

5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail.

Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R.

Biochem J. 2011 Jun 15;436(3):651-60. doi: 10.1042/BJ20101844.

PMID:
21410433
7.

Geminivirus-induced gene silencing of the tobacco retinoblastoma-related gene results in cell death and altered development.

Jordan CV, Shen W, Hanley-Bowdoin LK, Robertson DN.

Plant Mol Biol. 2007 Sep;65(1-2):163-75. Epub 2007 Jul 17.

PMID:
17634748
8.

Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF).

Johnson MS, Robertson DN, Holland PJ, Lutz EM, Mitchell R.

Cell Signal. 2006 Oct;18(10):1793-800. Epub 2006 Mar 20.

PMID:
16545942
9.

Release-modulating factors strongly affecting steroid diffusion from silicone elastomer.

Nash HA, Robertson DN, Evans SJ.

J Pharm Sci. 2004 Oct;93(10):2420-30.

PMID:
15349952
10.

Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor.

Robertson DN, Johnson MS, Moggach LO, Holland PJ, Lutz EM, Mitchell R.

Mol Pharmacol. 2003 Nov;64(5):1239-50.

PMID:
14573774
11.

ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor.

Mitchell R, Robertson DN, Holland PJ, Collins D, Lutz EM, Johnson MS.

J Biol Chem. 2003 Sep 5;278(36):33818-30. Epub 2003 Jun 10.

12.

Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF.

Ronaldson E, Robertson DN, Johnson MS, Holland PJ, Mitchell R, Lutz EM.

Regul Pept. 2002 Nov 15;109(1-3):193-8.

PMID:
12409233
13.

Additional signals from VPAC/PAC family receptors.

McCulloch DA, MacKenzie CJ, Johnson MS, Robertson DN, Holland PJ, Ronaldson E, Lutz EM, Mitchell R.

Biochem Soc Trans. 2002 Aug;30(4):441-6. Review.

PMID:
12196111
14.

ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.

McCulloch DA, Lutz EM, Johnson MS, Robertson DN, MacKenzie CJ, Holland PJ, Mitchell R.

Mol Pharmacol. 2001 Jun;59(6):1523-32.

PMID:
11353814
15.

Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor.

MacKenzie CJ, Lutz EM, Johnson MS, Robertson DN, Holland PJ, Mitchell R.

Endocrinology. 2001 Mar;142(3):1209-17.

PMID:
11181537
16.

Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cells.

Johnson MS, Lutz EM, MacKenzie CJ, Wolbers WB, Robertson DN, Holland PJ, Mitchell R.

Endocrinology. 2000 Sep;141(9):3087-97.

PMID:
10965878
17.

A mother's care: Do we include the family when the situation is critical?

Robertson DN.

J Emerg Nurs. 1999 Jun;25(3):206-7. No abstract available.

PMID:
10346844
18.
19.

The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.

Dixon EJ, Wilsoncroft P, Robertson DN, Page CP.

Br J Pharmacol. 1989 Jul;97(3):717-22.

20.

The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways.

Robertson DN, Coyle AJ, Rhoden KJ, Grandordy B, Page CP, Barnes PJ.

Am Rev Respir Dis. 1988 Jun;137(6):1317-22.

PMID:
2849329
21.

The role of PAF in altered airway responsiveness.

Page CP, Robertson DN.

Prog Clin Biol Res. 1988;263:71-80. Review. No abstract available.

PMID:
3289016
22.

Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs.

Page CP, Robertson DN, Coyle AJ.

Agents Actions Suppl. 1988;23:173-85. Review. No abstract available.

PMID:
3051932
23.
24.

The effect of platelet activating factor on pulmonary beta-adrenoceptors.

Barnes PJ, Grandordy BM, Page CP, Rhoden KJ, Robertson DN.

Br J Pharmacol. 1987 Apr;90(4):709-15.

25.

Properties of PAF relevant to asthma.

Page CP, Robertson DN.

Agents Actions Suppl. 1987;21:67-76. Review. No abstract available.

PMID:
3314416
26.

Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits.

Robertson DN, Smith GM.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:204-7. No abstract available.

PMID:
2959049
27.

Sustained intrauterine release of levonorgestrel over five years.

Nilsson CG, Lahteenmaki PL, Luukkainen T, Robertson DN.

Fertil Steril. 1986 Jun;45(6):805-7.

PMID:
3086130
28.

CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen.

Robertson DN, Smith GM.

Eur J Pharmacol. 1986 Apr 9;123(1):91-7.

PMID:
3709663
29.
30.

Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.

Robertson DN, Diaz S, Alvarez-Sanchez F, Holma P, Mishell DR, Coutinho E, Brache V, Croxatto HB, Faundes A, Lacarra M, et al.

Contraception. 1985 Apr;31(4):351-9.

PMID:
3924476
31.

Long-term reversible contraception with levonorgestrel-releasing Silastic rods.

Roy S, Mishell DR Jr, Robertson DN, Krauss RM, Lacarra M, Duda MJ.

Am J Obstet Gynecol. 1984 Apr 1;148(7):1006-13.

PMID:
6424474
32.

Long-term experience with Norplant implants in international clinical trials.

Sivin I, Holma P, Diaz S, Alvarez-sanchez F, Robertson DN, Stern J.

Contracept Deliv Syst. 1984 Jan;5(1):53-62.

PMID:
12312745
33.

Scanning electron microscopy and X-ray microanalysis of foreign bodies associated with Silastic implants in humans.

Tatum AH, Shelburne JD, Ingram P, Robertson DN, Croxatto HB, Diaz S.

Contraception. 1983 Dec;28(6):543-52.

PMID:
6370587
34.

A four-year clinical study of NORPLANT implants.

Sivin I, Diaz S, Holma P, Alvarez-Sanchez F, Robertson DN.

Stud Fam Plann. 1983 Jun-Jul;14(6-7):184-91. No abstract available.

PMID:
6414121
35.

Three-year experience with NORPLANT subdermal contraception.

Sivin I, Sanchez FA, Diaz S, Holma P, Coutinho E, McDonald O, Robertson DN, Stern J.

Fertil Steril. 1983 Jun;39(6):799-808.

PMID:
6406273
36.

Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.

Robertson DN, Sivin I, Nash HA, Braun J, Dinh J.

Contraception. 1983 May;27(5):483-95.

PMID:
6411428
37.

Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.

Croxatto HB, Diaz S, Robertson DN, Pavez M.

Contraception. 1983 Mar;27(3):281-8.

PMID:
6406139
38.

The NORPLANT contraceptive method: a report on three years of use.

Sivin I, Alvarez-Sanchez F, Diaz S, McDonald O, Holma P, Coutinho E, Robertson DN.

Stud Fam Plann. 1982 Aug-Sep;13(8-9):258-61. No abstract available.

PMID:
6814021
39.

A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).

Diaz S, Pavez M, Miranda P, Robertson DN, Sivin I, Croxatto HB.

Contraception. 1982 May;25(5):447-56.

PMID:
6809423
40.

Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring.

Robertson DN, Alvarez F, Sivin I, Brache V, Stern J, Leon P, Faundes A.

Contraception. 1981 Oct;24(4):469-80.

PMID:
6797787
41.

Norplant: reversible implant contraception.

Sivin I, Robertson DN, Stern J, Croxatto HB, Diaz S, Coutinho E, da Silva AR, Alvarez Sanchez F, Faundes A, McDonald O, Holma P, Nielsen NC, Osler M, Nash HA.

Stud Fam Plann. 1980 Jul-Aug;11(7-8):227-35. No abstract available.

PMID:
6996230
42.

Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.

Nilsson CG, Lähteenmäki P, Robertson DN, Luukkainen T.

Acta Endocrinol (Copenh). 1980 Mar;93(3):380-4.

PMID:
7376797
43.

A three-year clinical trial with levonorgestrel silastic implants.

Diaz S, Pavez M, Robertson DN, Croxatto HB.

Contraception. 1979 Jun;19(6):557-73.

PMID:
385243
44.

Clinical trial with subdermal implants containing norgestrienone.

Diaz S, Pavez M, Quinteros E, Diaz J, Robertson DN, Croxatto HB.

Contraception. 1978 Oct;18(4):429-40.

PMID:
720075
45.

Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels.

Nash HA, Robertson DN, Jackanicz TM.

Contraception. 1978 Oct;18(4):395-409.

PMID:
720073
46.

Steroid release from silastic capsules and rods.

Nash HA, Robertson DN, Moo Young AJ, Atkinson LE.

Contraception. 1978 Oct;18(4):367-94. No abstract available.

PMID:
720072
47.

Comparative clinical trial of the progestins R-2323 and levonorgestrel administered by subdermal implants.

Alvarez F, Robertson DN, Montes de Oca V, Sivin I, Brache V, Faundes A.

Contraception. 1978 Aug;18(2):151-62. No abstract available.

PMID:
249677
48.

Clinical trial with subdermal implants of the progestin R-2323.

Diaz S, Pavez M, Quniteros E, Robertson DN, Croxatto HB.

Contraception. 1977 Aug;16(2):155-65.

PMID:
913113
49.

Pregnancy and labour in the paraplegic.

Robertson DN.

Paraplegia. 1972 Nov;10(3):209-12. No abstract available.

50.

The paraplegic patient in pregnancy and labour.

ROBERTSON DN, GUTTMANN L.

Proc R Soc Med. 1963 May;56:381-7. No abstract available.

Supplemental Content

Loading ...
Support Center